PARP1 and Alzheimer disease: Furthermore, PARP1 reduction in the nucleus, leading to activation of DNA cytosine-5-methyltransferase 1 and silencing of nucleolar rRNA gene (rDNA), was implicated as an early marker of cognitive impairment in AD [209].